Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.041 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |